Skip to main content

About Eleven Therapeutics

Eleven Therapeutics is revolutionizing the field of nucleic acid therapeutics by integrating cutting-edge RNA biology, combinatorial chemistry, and artificial intelligence to generate a programmable drug discovery and development platform. Our multidisciplinary team operates at the intersection of bioengineering, chemistry, genomics, and computational science. With a pipeline targeting cardiometabolic and endocrine disorders, we are at the forefront of developing novel therapeutics. We foster a culture of collaboration, diversity, and scientific excellence across our hubs in Cambridge (UK), Tel Aviv (Israel), and Boston (US).

The Opportunity

Are you a visionary translational scientist with a "get-it-done" startup mentality? Do you want to lead the charge in moving life-saving xRNA therapies from the lab bench into the clinic?

We are seeking a high-energy, hands-on VP of Preclinical & Translational Medicine to bridge the gap between discovery and the patient. In this pivotal role, you will be the architect of our pipeline’s transition into clinical reality. Working alongside our VP of Discovery, you will lead a lean, agile team (and a network of world-class CROs) to validate our xRNA-LNP platforms in cardiometabolic models. This is not a desk job, it is a role for a leader who thrives on data, loves troubleshooting complex biological puzzles, and isn't afraid to dive into the technical weeds to meet aggressive milestones.

Application Closing Date:
8 May 2026
Salary:
Competitive